PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,187 | +7.9% | 13,010,000 | -16.1% | 5.34% | +6.8% |
| Q1 2023 | $15,930 | -14.5% | 15,510,000 | 0.0% | 5.00% | -10.0% |
| Q4 2022 | $18,638 | -99.9% | 15,510,000 | 0.0% | 5.56% | -9.4% |
| Q3 2022 | $19,599,000 | +9.3% | 15,510,000 | -2.8% | 6.13% | +23.7% |
| Q2 2022 | $17,925,000 | -21.1% | 15,960,000 | -20.4% | 4.96% | -10.9% |
| Q1 2022 | $22,713,000 | -8.4% | 20,060,000 | -4.7% | 5.56% | -1.2% |
| Q4 2021 | $24,802,000 | +2.6% | 21,060,000 | 0.0% | 5.63% | -10.9% |
| Q3 2021 | $24,177,000 | -1.8% | 21,060,000 | 0.0% | 6.32% | +9.7% |
| Q2 2021 | $24,611,000 | +5.6% | 21,060,000 | +5.0% | 5.76% | +1.8% |
| Q1 2021 | $23,311,000 | +3.9% | 20,060,000 | 0.0% | 5.66% | -0.8% |
| Q4 2020 | $22,444,000 | -0.5% | 20,060,000 | 0.0% | 5.71% | -9.0% |
| Q3 2020 | $22,558,000 | +0.4% | 20,060,000 | 0.0% | 6.27% | +3.3% |
| Q2 2020 | $22,462,000 | -5.1% | 20,060,000 | -4.7% | 6.07% | -17.8% |
| Q1 2020 | $23,672,000 | +61.5% | 21,060,000 | +35.3% | 7.39% | +79.6% |
| Q4 2019 | $14,659,000 | +57.6% | 15,560,000 | +19.1% | 4.11% | +31.5% |
| Q3 2019 | $9,300,000 | +49.3% | 13,060,000 | +44.2% | 3.13% | +40.8% |
| Q2 2019 | $6,228,000 | – | 9,060,000 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |